- Home
- ASRV vs ANVS Comparison
ASRV vs ANVS Comparison
Compare ASRV & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- ANVS
- Stock Information
- Founded
- ASRV 1983
- ANVS 2008
- Country
- ASRV United States
- ANVS United States
- Employees
- ASRV N/A
- ANVS N/A
- Industry
- ASRV Major Banks
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- ANVS Health Care
- Exchange
- ASRV Nasdaq
- ANVS Nasdaq
- Market Cap
- ASRV 51.0M
- ANVS 55.5M
- IPO Year
- ASRV N/A
- ANVS 2020
- Fundamental
- Price
- ASRV $2.80
- ANVS $2.73
- Analyst Decision
- ASRV
- ANVS Strong Buy
- Analyst Count
- ASRV 0
- ANVS 4
- Target Price
- ASRV N/A
- ANVS $18.00
- AVG Volume (30 Days)
- ASRV 29.0K
- ANVS 334.5K
- Earning Date
- ASRV 07-22-2025
- ANVS 08-14-2025
- Dividend Yield
- ASRV 4.20%
- ANVS N/A
- EPS Growth
- ASRV N/A
- ANVS N/A
- EPS
- ASRV 0.22
- ANVS N/A
- Revenue
- ASRV $51,581,000.00
- ANVS N/A
- Revenue This Year
- ASRV N/A
- ANVS N/A
- Revenue Next Year
- ASRV N/A
- ANVS N/A
- P/E Ratio
- ASRV $12.88
- ANVS N/A
- Revenue Growth
- ASRV 13.95
- ANVS N/A
- 52 Week Low
- ASRV $2.03
- ANVS $1.11
- 52 Week High
- ASRV $3.42
- ANVS $10.65
- Technical
- Relative Strength Index (RSI)
- ASRV 36.74
- ANVS 52.50
- Support Level
- ASRV $2.73
- ANVS $2.63
- Resistance Level
- ASRV $2.99
- ANVS $3.00
- Average True Range (ATR)
- ASRV 0.15
- ANVS 0.22
- MACD
- ASRV -0.05
- ANVS -0.00
- Stochastic Oscillator
- ASRV 11.86
- ANVS 43.75
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.